Breast masses
LEASING The Letter of Intent Presented by: Sean P. Callan.
Screening for Substance Abusers in a Primary Care Setting Matthew Torrington, M.D., Richard Rawson, Ph.D. Matthew Torrington, M.D., Richard Rawson, Ph.D.
ESRD Network 6 (Southeastern Kidney Council) ESRD Network 6 5 Diamond Patient Safety Program What is Patient Safety?
Diagnosis and Treatment of Opioid Dependence Matthew A. Torrington, MD AAFP ASAM Medical Director, Matrix Institute Narcotic Treatment Program Clinical.
Buprenorphine in the treatment of addiction Matthew A. Torrington MD Clinical Research Physician UCLA: Integrated Substance Abuse Programs Matrix Institute.
Roadway Extrication. 2 Introduction 40 hour course –minimum attendance is 90% –end of course exam 80% or better –practical examination-must pass all evolutions.
Buprenorphine and the Office- Based Treatment of Opiate Dependence Matthew A. Torrington, MD AAFP ASAM Medical Director Matrix Institute, Narcotic Treatment.
Laboratory Lessons Mrs. Brown’s Room. I. Lab Safety.
NEXT 100 Winners Book
